Proceedings of the National Academy of Sciences · 2024 · 11 citations · 9 references
Veterinary MedicineMolecular BiologyMolecular GeneticsAgingCell SignalingInflammationEndothelial ActivationEndothelial DysfunctionAtherosclerosis GeneticsAtherosclerosis Molecular MechanismsAtherosclerosis RiskPcsk9 Gain-of-function Mutations
Hutchinson–Gilford progeria syndrome (HGPS) is a rare disease caused by the expression of progerin, a mutant protein that accelerates aging and precipitates death. Given that atherosclerosis complications are the main cause of death in progeria, here, we investigated whether progerin-induced atherosclerosis is prevented in HGPSrev-Cdh5-CreERT2 and HGPSrev-SM22α-Cre mice with progerin suppression in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), respectively. HGPSrev-Cdh5-CreERT2 mice were undistinguishable from HGPSrev mice with ubiquitous progerin expression, in contrast with the ameliorated progeroid phenotype of HGPSrev-SM22α-Cre mice. To study atherosclerosis, we generated atheroprone mouse models by overexpressing a PCSK9 gain-of-function mutant. While HGPSrev-Cdh5-CreERT2 and HGPSrev mice developed a similar level of excessive atherosclerosis, plaque development in HGPSrev-SM22α-Cre mice was reduced to wild-type levels. Our studies demonstrate that progerin suppression in VSMCs, but not in ECs, prevents exacerbated atherosclerosis in progeroid mice.
9
In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice
Luke W. Koblan, Michael R. Erdos, Christopher Wilson et al. · Nature · 2021 · 494 citations · Full text